Cytosorbents Corporation Receivables Turnover Ratio (CTSO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytosorbents Corporation  (NASDAQ: CTSO)
 

Cytosorbents Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Cytosorbents Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.93, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Cytosorbents in Jun 30 2026 quarter, has decreased to 74 days, compared to 78 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 379 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1165 to 2818.

What is Receivable Turnover Ratio?
What is Cytosorbents Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTSO Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change -12.36 % -6.76 % 3.15 % 11.98 % -1.02 %
Y / Y Revenue Change 9.29 % -0.95 % 41.55 % -6.63 % -7.25 %
Receivable Turnover Ratio (TTM) 4.93 4.67 4.6 4.27 4.47
CTSO's Total Ranking # 2818 # 1165 # 2483 # 1492 # 1927
Accounts Receivable average collection period days 74 78 79 85 82
Seq. Receivable Change -5.12 % -5.27 % 1.66 % -4.08 % 0.95 %
Seq. Revenue Change 18.49 % -11.95 % 6.55 % -1.68 % 7.39 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 142
Healthcare Sector # 380
Overall Market # 2818

Receivable Turnover Ratio Statistics
High Average Low
28.74 8.55 4.27
(Dec 31 2012)   (Sep 30 2025)




  News about Cytosorbents Corporation Receivables Turnover Ratios

Balancing Innovation and Financial Hurdles CytoSorbents Journey with DrugSorb-ATR and Market Realities

: This article provides a analysis of recent developments related to CytoSorbents Corporation s new product, DrugSorb-ATR, designed to mitigate bleeding risks in heart bypass surgery patients on ticagrelor. This novel therapy emerges amid a challenging financial landscape, marked by decreasing receivable collections and a competitive medical equipment industry. This analysis integrates facts from regulatory progress, potential clinical impact, and financial challenges to present a comprehensive picture of CytoSorbents current trajectory. Regulatory Progress and Clinical Implication: CytoSorbents Corporation has made significant strides by filing a De Novo marketing application to the U.S. Food and Drug Administration (FDA) for DrugSorb-ATR. This innovative technology is tailored to reduce the severity of bleeding in patients undergoing coronary artery bypass grafting (CABG) surgery while on the anticoagulant ticagrelor, a scenario long recognized for its complexities and bleeding risk.


CTSO Company Profile • Back to CTSO Efficiency Comparisons • Compare CTSO Receivables Turnover Ratio to its Competitors

Financial Statements
Cytosorbents's Accounts Receivable $ 7 Millions Visit CTSO's Balance sheet
Cytosorbents's Sales TTM $ 36 Millions Visit CTSO's Income Statement
Sources of CTSO's Revenues Visit CTSO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CTSO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CTSO's Growth Rates CTSO's Roa CTSO's Inventory Turnover Ratio CTSO's Dividend Comparisons
CTSO's Profitability Ratios CTSO's Roi CTSO's Asset Turnover Ratio CTSO's Dividend Growth
CTSO's Valuation Ratios CTSO's Roe CTSO's Financial Strength Ratios CTSO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Skinhealth Systems Inc   14.42 $ 289.224  Millions$ 20.051  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
10x Genomics Inc   13.90 $ 616.566  Millions$ 44.342  Millions
Amneal Pharmaceuticals Inc   13.90 $ 3,117.474  Millions$ 224.342  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Corcept Therapeutics Inc  13.54 $ 830.813  Millions$ 61.352  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Nrc Health  12.72 $ 139.996  Millions$ 11.004  Millions
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions

Date modified: 2026-10-15T05:23:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.